Search

everythinglearnresearchcommunity

for

Search:↓

People with atopic dermatitis have more CD4+ T cells that respond to a certain bacterial lipid, which may play a role in the skin condition's inflammation.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Blocking IL-1 could help treat some hair loss conditions; alopecia affects liver detox systems; spironolactone is better than finasteride for female hair growth; focusing on the catagen hair phase could lead to new alopecia treatments.

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Pure carbon nanotubes are safe for mice, but impure ones cause immune issues and hair loss.

New treatments and diagnostic methods for urological conditions show promise, but some lack sufficient accuracy for clinical use.

COVID-19 may trigger systemic lupus erythematosus, requiring careful diagnosis and treatment.

Biologics, especially Dupilumab, are effective and safe for treating severe childhood eczema.

Chitosan-based dressings reduce inflammation and speed up skin wound healing.

Mesenchymal Stem Cell therapy shows promise for treating hair loss in Alopecia Areata.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

PRP therapy shows promise in healing and tissue repair across various medical fields but needs more research for standardization and optimization.

Apremilast shows promise for several skin conditions but needs more research.

People with alopecia areata have higher levels of osteopontin, which might be important in the disease's development, but this doesn't relate to how severe the disease is.

Tofacitinib improved arthritis and partially improved hair loss in a lupus patient without side effects.

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

Alopecia patients have a less active liver monoxygenase system, which can be treated with photochemotherapy and system inducers.

The Multi-Organ-Chip improves the growth and quality of skin and hair in the lab, potentially replacing animal testing.

Targeting CD200 could be a new treatment for rheumatoid arthritis.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

Minoxidil helps prevent hair loss from chemotherapy in rats.

Mongolian gerbils heal wounds differently than mice, with unique protein levels and gene expression that affect skin repair.

CD2 might be a new treatment target for patchy alopecia areata.

A man's hair regrew from alopecia areata after using tofacitinib and experiencing contact dermatitis from a wig device.

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Freezing gamma-irradiated amniotic fluid may help hair growth and speed up the growth phase.